| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |